Cargando…
mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching
Cells maintain and dynamically change their proteomes according to the environment and their needs. Mechanistic target of rapamycin (mTOR) is a key regulator of proteostasis, homeostasis of the proteome. Thus, dysregulation of mTOR leads to changes in proteostasis and the consequent progression of d...
Autores principales: | Shin, Sejeong, Han, Min-Joon, Jedrychowski, Mark P., Zhang, Ziyang, Shokat, Kevan M., Plas, David R., Dephoure, Noah, Yoon, Sang-Oh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528759/ https://www.ncbi.nlm.nih.gov/pubmed/37494188 http://dx.doi.org/10.1016/j.celrep.2023.112868 |
Ejemplares similares
-
Brain-restricted mTOR inhibition with binary pharmacology
por: Zhang, Ziyang, et al.
Publicado: (2022) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014) -
Tissue-restricted inhibition of mTOR using chemical genetics
por: Wassarman, Douglas R., et al.
Publicado: (2022) -
Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016) -
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming
por: Geter, Phillip A., et al.
Publicado: (2017)